| Bioactivity | Arg-Gly-Asp-Cys is the binding motif of fibronectin to cell adhesion molecules, and can inhibit platelet aggregation and fibrinogen binding. | ||||||
| Invitro | RGDC immobilizes peptide onto DAH-CMTMC is found to be about 15.3 μg/mg of chitosan derivative by amino acid analysis (AAA). RGDC-functionalized chitosan may lead to enhanced wound healing (viability >140%). RGDC-functionalizes chitosan derivatives exhibit in vitro wound healing properties by enhancing fibroblast proliferation and adhesion. RGDC-DAH-CMTMC favors cell growth and an increase in cellular proliferation compared to the control cells[1]. | ||||||
| Name | Arg-Gly-Asp-Cys | ||||||
| CAS | 109292-46-8 | ||||||
| Shortening | RGDC | ||||||
| Formula | C15H27N7O7S | ||||||
| Molar Mass | 449.48 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Arg-Gly-Asp-Cys
CAS: 109292-46-8 F: C15H27N7O7S W: 449.48
Arg-Gly-Asp-Cys is the binding motif of fibronectin to cell adhesion molecules, and can inhibit platelet aggregation and
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.